| 注册
首页|期刊导航|中国药物经济学|卵巢癌治疗的卫生经济学评价研究进展

卵巢癌治疗的卫生经济学评价研究进展

张敏 陈春岚 浦科学

中国药物经济学2024,Vol.19Issue(2):17-20,25,5.
中国药物经济学2024,Vol.19Issue(2):17-20,25,5.DOI:10.12010/j.issn.1673-5846.2024.02.003

卵巢癌治疗的卫生经济学评价研究进展

Research Progress on Health Economics Evaluation of Ovarian Cancer Treatment

张敏 1陈春岚 1浦科学1

作者信息

  • 1. 重庆医科大学医学信息学院,重庆 400016
  • 折叠

摘要

Abstract

In recent years,the incidence rate of ovarian cancer in our country increases year by year.As a kind of malignant tumor which has serious threat to women's life and health,ovarian cancer is usually treated mainly by surgery,supplemented by postoperative radiotherapy and chemotherapy,but its treatment cost is high.In this context,health economic evaluation of the treatment of ovarian cancer is particularly important.At present,the health economics evaluation of ovarian cancer treatment at home and abroad mainly focuses on initial treatment and the treatment after recurrence.This paper reviews the health economics evaluation of ovarian cancer treatment,tracks the forefront of the treatment of ovarian cancer,discusses the shortcomings of the current research,and predicts the future direction of research,so as to provide reference for the economic research of the treatment of ovarian cancer.

关键词

卵巢癌/卫生经济学评价/成本-效果分析/研究进展

Key words

Ovarian cancer/Health economics evaluation/Cost-effectiveness analysis/The research progress

分类

医药卫生

引用本文复制引用

张敏,陈春岚,浦科学..卵巢癌治疗的卫生经济学评价研究进展[J].中国药物经济学,2024,19(2):17-20,25,5.

基金项目

重庆医科大学哲学社会科学创新团队项目(ZX190101) (ZX190101)

重庆医科大学未来医学青年创新团队项目(W0081) (W0081)

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文